Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$139000.0.

  • Rockwell Medical's Change in Accured Expenses fell 14005.76% to -$139000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 265212.77%. This contributed to the annual value of -$1.0 million for FY2024, which is 17500.0% down from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Change in Accured Expenses is -$139000.0, which was down 14005.76% from -$503000.0 recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Change in Accured Expenses peaked at $2.9 million during Q3 2023, and registered a low of -$3.3 million during Q1 2023.
  • Moreover, its 5-year median value for Change in Accured Expenses was -$139000.0 (2025), whereas its average is -$64631.6.
  • Per our database at Business Quant, Rockwell Medical's Change in Accured Expenses surged by 60000.0% in 2021 and then crashed by 41484.38% in 2023.
  • Rockwell Medical's Change in Accured Expenses (Quarter) stood at $777000.0 in 2021, then surged by 128.83% to $1.8 million in 2022, then crashed by 63.05% to $657000.0 in 2023, then plummeted by 143.07% to -$283000.0 in 2024, then skyrocketed by 50.88% to -$139000.0 in 2025.
  • Its Change in Accured Expenses stands at -$139000.0 for Q3 2025, versus -$503000.0 for Q2 2025 and -$1.7 million for Q1 2025.